Summary

Overview
The global interventional imaging market reached US$ 9.21 billion in 2024 and is expected to reach US$ 16.64 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.
Interventional imaging refers to the use of advanced imaging techniques to guide and assist minimally invasive procedures or interventions. It involves real-time imaging technology to visualize internal structures of the body during medical treatments, enabling healthcare professionals to perform procedures with high precision and accuracy. Interventional imaging provides continuous, real-time visualization of the target area, such as blood vessels, organs, or tissues, during a procedure. This is essential for ensuring the correct placement of instruments and minimizing damage to surrounding tissues.
The interventional imaging market is experiencing significant growth, driven by a rising preference for minimally invasive procedures, a rising prevalence of chronic diseases and increasing technological advancements. For instance, in June 2024, GE HealthCare and MediView XR Inc. released the first installation of the OmnifyXR interventional suite. It combines a holographic heads-up display that streams real-time medical images with three-dimensional (3D) anatomical model visualization and powerful imaging technology. It enables remote cooperation for the delivery of precision care across a wide range of intervention techniques.
Market Dynamics: Drivers & Restraints
Rising technological advancements
The rising technological advancements are significantly driving the growth of the interventional imaging market and are expected to drive the market over the forecast period by enhancing the accuracy, speed, and safety of minimally invasive procedures. Artificial intelligence is transforming interventional imaging by improving visualization, image analysis, real-time decision-making, and predictive modeling. AI algorithms can quickly identify abnormalities, such as tumors or blockages, from imaging data, helping clinicians make faster, more accurate decisions.
For instance, in December 2024, Royal Philips announced a boost in confidence in clinical decision support with AI and smart workflow automation capabilities in the recently introduced CT 5300 system. Philips CT 5300 combines innovative hardware, software and artificial intelligence for high-quality screening, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications.
Additionally, 3D and 4D imaging provide real-time, high-resolution views of the body’s structures, aiding in precise navigation during interventions. This technology is crucial for guiding procedures like angioplasty, biopsy, and tumor ablation. The adoption of 3D and 4D imaging is expected to increase rapidly, contributing to market growth, especially in regions with high healthcare infrastructure, like North America and Europe.
For instance, in August 2024, Siemens Healthineers announced that ACUSON Origin, a new specialized cardiovascular ultrasound system with artificial intelligence (AI) characteristics, has received FDA clearance. These qualities can help physicians execute cardiac operations more effectively, such as diagnostics, structural heart disease, and electrophysiology. The new AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter, which is only compatible with the ACUSON Origin, enables improved imaging for difficult heart surgeries.
Strict regulatory frameworks
Strict regulatory frameworks pose a significant challenge to the growth of the interventional imaging market by creating delays, adding costs and restricting the speed at which new technologies can be adopted. Regulatory bodies, such as the FDA (Food and Drug Administration) in the U.S. and the European Medicines Agency (EMA) in Europe, impose stringent approval processes for medical devices, including interventional imaging systems. These processes often involve extensive clinical trials, documentation, and reviews before products can be introduced to the market.
Regulatory standards for medical devices vary significantly across regions. These differences complicate the global market strategy for interventional imaging companies, as they must adhere to different approval processes and certification requirements in each region (e.g., FDA in the U.S., CE marking in Europe, and TGA in Australia).
For instance, a product approved by the FDA might not be immediately eligible for sale in the EU or Asia due to differences in safety and efficacy standards. This requires additional testing and certifications, which can delay market entry and increase operational complexity. These regional regulatory discrepancies create barriers for companies trying to expand globally and slow down the growth of the market in non-compliant regions, limiting access to the latest technologies.
Segment Analysis
The global interventional imaging market is segmented based on product type, imaging modality, application, procedure type, end-user and region.
Product Type:
The interventional imaging systems segment is expected to dominate the interventional imaging market share
Interventional imaging systems such as MRI systems, ultrasound imaging systems and angiography systems provide real-time, detailed visual guidance during minimally invasive procedures, such as angioplasty, biopsy and tumor ablation. These systems are integral to ensuring precise targeting, reducing complications, and improving patient outcomes.
For instance, in cardiology, systems like GE Healthcare’s fluoroscopy systems are widely used to guide procedures such as coronary angioplasty and stent placement, ensuring correct catheter positioning in real time. The demand for such procedures, which benefit from precise guidance, is increasing, positioning interventional imaging systems as the market leader.
Advanced imaging technologies, such as 3D/4D imaging, robotic-assisted systems and AI-powered diagnostic tools, are transforming interventional imaging systems, enhancing their accuracy, efficiency, and applicability. For instance, the Siemens Healthineers’ ARTIS pheno system integrates 3D imaging with cutting-edge advanced robotic-assisted interventions, for multiple surgical and interventional procedures. The continuous innovation in imaging systems, such as the integration of AI for faster and more accurate imaging analysis, ensures their dominance in the interventional imaging market.
Geographical Analysis
North America is expected to hold a significant position in the interventional imaging market share
North America, particularly the United States, is home to major medical imaging companies such as GE Healthcare, Philips, and Siemens Healthineers. These companies are at the forefront of developing and commercializing new imaging technologies, including 3D/4D imaging, robotic-assisted interventions, and AI-powered imaging systems.
For instance, in November 2024, Philips Healthcare launched a limited release of the LumiGuide system, a new light-based catheter guidance system for cath labs that represents a step toward radiation-free interventional imaging. The focus of the technology is endovascular aortic procedures. LumiGuide system works exclusively with compatible Philips interventional systems such as Azurion and is the second-generation solution to use FORS. These continuous technological advancements and innovations in the region solidify North America's position as a leader in the interventional imaging market.
There is a rising preference for minimally invasive procedures in North America due to the benefits of shorter recovery times, reduced risks, and lower healthcare costs. Interventional imaging systems are essential in guiding these procedures with precision, which further drives their demand. For instance, the growing use of angioplasty and stent placement procedures for coronary artery disease (CAD) is driving the demand for advanced fluoroscopy and angiography systems in the U.S. The increasing demand for minimally invasive procedures is fueling the growth of the interventional imaging market in North America, as these systems are crucial for performing such interventions with high accuracy.
Asia-Pacific is growing at the fastest pace in the interventional imaging market
Asia-Pacific is seeing an influx of technological advancements in interventional imaging, with an increasing number of local manufacturers producing cost-effective, high-quality imaging systems. This trend is driving adoption by making interventional imaging more accessible in emerging markets. The presence of leading manufacturers such as India’s Medtronic and Philips India and more affordable imaging systems are driving the growth of the interventional imaging market in the region, making advanced technologies more accessible to a broader population.
For instance, in November 2024, Philips India launched the new Azurion to expert interventionalists in cardiology, neurology, vascular medicine, and surgery in India. The new interventional system is intended to speed up neurovascular operations and assist care teams in making the correct decisions faster, treating more patients, and achieving better results. It has increased C-arm rotation and angulation. It also includes parking facilities for quick transitions from 2D to 3D imaging, comprehensive table-side control that eliminates the need to leave the sterile field, automatic beam rotation to obtain correctly oriented images for all angulations and rotations, and a new head immobilizer to support improved stroke care.
Competitive Landscape
The major global players in the interventional imaging market include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, CANON MEDICAL SYSTEMS USA, INC., FUJIFILM Holdings Corporation, Lumibird Medical, Boston Scientific Corporation, Terumo Corporation, Guerbet, Shimadzu Corporation and among others.
Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global interventional imaging market report delivers a detailed analysis with 78 key tables, more than 80 visually impactful figures, and 167 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.

• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.

• Supply Chain: Distribution and Supply Chain Managers.

• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

• Academic & Research: Academic Institutions.

ページTOPに戻る

Table of Contents

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Imaging Modality
2.5. Snippet by Application
2.6. Snippet by Procedure Type
2.7. Snippet by End-User
2.8. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Technological Advancements
3.1.2. Restraints
3.1.2.1. Strict Regulatory Frameworks
3.1.3. Opportunity
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest selling Brand
4.1.3. Market leaders with established Product
4.2. Emerging Startups and Key Innovators
4.3. CXO Perspectives
4.4. Latest Developments and Breakthroughs
4.5. Case Studies/Ongoing Research
4.6. Regulatory and Reimbursement Landscape
4.6.1. North America
4.6.2. Europe
4.6.3. Asia Pacific
4.6.4. Latin America
4.6.5. Middle East & Africa
4.7. Porter’s Five Force Analysis
4.8. Supply Chain Analysis
4.9. Patent Analysis
4.10. SWOT Analysis
4.11. Unmet Needs and Gaps
4.12. Recommended Strategies for Market Entry and Expansion
4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.14. Pricing Analysis and Price Dynamics
5. Interventional Imaging Market, By Product Type
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Interventional Imaging Systems*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3. MRI Systems
5.2.4. Ultrasound Imaging Systems
5.2.5. CT Scanners
5.2.6. Angiography Systems
5.2.7. Others
5.3. Interventional Imaging Accessories
5.3.1. X-ray Detectors
5.3.2. C-arms
5.3.3. Image Intensifiers
5.4. Software
5.5. Consumables
5.5.1. Catheters
5.5.2. Guidewires
5.5.3. Needles
5.5.4. Others
6. Interventional Imaging Market, By Imaging Modality
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
6.1.2. Market Attractiveness Index, By Imaging Modality
6.2. X-Ray Imaging*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Computed Tomography (CT)
6.4. Magnetic Resonance Imaging (MRI)
6.5. Ultrasound Imaging
6.6. Others
7. Interventional Imaging Market, By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Cardiology*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Oncology
7.4. Neurology
7.5. Urology and Nephrology
7.6. Gastroenterology
7.7. Musculoskeletal
7.8. Others
8. Interventional Imaging Market, By Procedure Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
8.1.2. Market Attractiveness Index, By Procedure Type
8.2. Diagnostic Procedure*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Therapeutic Procedure
9. Interventional Imaging Market, By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Diagnostic Centers
9.5. Ambulatory Surgical Centers
9.6. Others
10. Interventional Imaging Market, By Regional Market Analysis and Growth Opportunities
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.8.1. U.S.
10.2.8.2. Canada
10.2.8.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.8.1. Germany
10.3.8.2. U.K.
10.3.8.3. France
10.3.8.4. Spain
10.3.8.5. Italy
10.3.8.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.8.1. Brazil
10.4.8.2. Argentina
10.4.8.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.8.1. China
10.5.8.2. India
10.5.8.3. Japan
10.5.8.4. South Korea
10.5.8.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Modality
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape and Market Positioning
11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking
12. Company Profiles
12.1. GE HealthCare*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.2. Koninklijke Philips N.V.
12.3. Siemens Healthineers AG
12.4. CANON MEDICAL SYSTEMS USA, INC.
12.5. FUJIFILM Holdings Corporation
12.6. Lumibird Medical
12.7. Boston Scientific Corporation
12.8. Terumo Corporation
12.9. Guerbet
12.10. Shimadzu Corporation
LIST NOT EXHAUSTIVE
13. Assumption and Research Methodology
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. Appendix
14.1. About Us and Services
14.2. Contact Us